CompletedNot Applicable

Drusen Morphology Changes in Nonexudative Age-related Degeneration After Oral Antioxidants Supplementation

35 participantsStarted 2013-01

Plain-language summary

Purpose: To determine drusen morphology (volume and area) changes in nonexudative age-related macular degeneration (AMD) after one year of oral supplementation with AREDS-like formulation.

Who can participate

Age range50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * AREDS category 2 and 3 AMD Exclusion Criteria: * AREDS category 4 AMD * other ophthalmological diseases * currently on antioxidant supplementation

What they're measuring

Drusen volume change

Timeframe: 12 months

Trial details

NCT IDNCT02264938

SponsorGermans Trias i Pujol Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-07

View on ClinicalTrials.gov More Macular Degeneration trials